Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
Professor Emmett will showcase data from her OPTIMAL-PSMA 2 investigator-initiated trial of TLX597-Tx ( 177 Lu-DOTA-PSMA), Telix’s novel second generation small molecule candidate being developed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results